SCHEMBL1695131

SCHEMBL1695131

O=C(OC(=O)c1cc(Br)cc2ccccc12)c1cc(Br)cc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
RXFP1 Q9HBX9 1/20 0.45
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ACP1 P24666 1/20 0.41
KDM4E B2RXH2 4/20 0.41
MMP3 P08254 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1071827 0.86 ALDH1A1 (0.56) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL30344464 0.81 MEN1 (0.65) KMT2AMEN1RXFP1ALDH1A1HPGD
SCHEMBL1228020 0.81 MEN1 (0.65) KMT2AMEN1RXFP1ALDH1A1HPGD
SCHEMBL4962003 0.81 KMT2A (0.47) KMT2AMEN1RXFP1ALDH1A1HPGD
SCHEMBL4168214 0.80 ALDH1A1 (0.47) KMT2AMEN1RXFP1ALDH1A1HPGD
SCHEMBL2184938 0.80 KDM4E (0.53) KMT2AMEN1RXFP1ALDH1A1HPGD
SCHEMBL4957630 0.80 KDM4E (0.41) KMT2AMEN1ALDH1A1HPGDATM
SCHEMBL600272 0.80 CDC25B (0.58) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL30016538 0.80 KDM4E (0.53) KMT2AMEN1RXFP1ALDH1A1HPGD
SCHEMBL15591156 0.80 MEN1 (0.46) KMT2AMEN1RXFP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107250114-B Sulfonic acid derivative compound, photoacid generator, resist composition, cationic polymerization initiator, and cationically polymerizable composition 株式会社ADEKA 2020-11-06 CN disclosed
EP-3272737-B1 SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORP (JP) 2019-07-24 EP disclosed
US-20180079724-A1 SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2018-03-22 US disclosed
EP-3272737-A1 SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION Adeka Corporation (JP) 2018-01-24 EP disclosed
CN-107250114-A Sulfonic acid derivative compound, photoacid generator, resist composition, cationic polymerization initiator, and cationically polymerizable composition 株式会社ADEKA 2017-10-13 CN disclosed
CN-104507906-B Novel EP2 receptor agonists 塔科达有限责任公司 2017-04-12 CN disclosed
US-8969573-B2 Compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-03 US disclosed
WO-2015013456-A1 INDICATOR COMPOUNDS, POLYMERIZABLE DERIVATIVES THEREOF AND INFECTION INDICATING MEDICAL DEVICES COMPRISING THE SAME INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2015-01-29 WO disclosed
EP-1871844-B1 BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2014-08-27 EP disclosed
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed
US-20070010400-A1 Use of color changing indicators in consumer products C2C TECHNOLOGIES, LLC 2007-01-11 US disclosed
US-20060257439-A1 Cleansing compositions with color changing indicator CRAYOLA LLC 2006-11-16 US disclosed
US-20060236470-A1 Novelty compositions with color changing indicator CRAYOLA LLC 2006-10-26 US disclosed
WO-2006105193-A2 PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105260-A1 ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105261-A1 CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105191-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
US-20060222675-A1 Personal care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
US-20060222601-A1 Oral care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
US-4582910-A Method for preparation of 4-halogenonaphthalic acid anhydrides RUTGERSWERKE AKTIENGESELLSCHAFT (DE) 1986-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060222675-A1 Personal care compositions with color changing indicator CUTA, POLR1C, TYR KMT2A 3653/4885MEN1 2817/4885RXFP1 1951/4885
US-20060257439-A1 Cleansing compositions with color changing indicator WASHC5, WASHC4, FHIT KMT2A 3047/4885MEN1 1113/4885RXFP1 4861/4885
US-20180079724-A1 SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION ALAD, ADSL, ACSL3 KMT2A 3429/4885MEN1 4527/4885RXFP1 4173/4885
US-20060222601-A1 Oral care compositions with color changing indicator CA9, CA7, TAS2R7 KMT2A 2738/4885MEN1 3449/4885RXFP1 4515/4885
US-20070010400-A1 Use of color changing indicators in consumer products NQO2, CA4, CA7 KMT2A 1465/4885MEN1 3755/4885RXFP1 4006/4885
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation MKI67, EIF2AK2, CDK2 KMT2A 3071/4885MEN1 3017/4885RXFP1 4622/4885
US-20060236470-A1 Novelty compositions with color changing indicator MITF, CRABP2, SHH KMT2A 1508/4885MEN1 3006/4885RXFP1 3537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.